Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Prevention of Cognitive Late Effects in Pediatric Brain Tumor Patients
NCT03194906Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Nov 2017
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cognitive impairment comparing Memantine with Placebo (2 arms). Primary endpoints: Percent of Approached Participants Who Consent to Study Participation, Percent of Participants Who Complete All 12 Weeks of Memantine/Placebo Therapy and 1 more. Started Nov 2017; status: completed.
02
Drugs
memantine
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT03194906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03194906.